The $19M purchase by ARCH affiliates at $15 is a strong insider signal from the company's largest holders. Monitor for any upcoming corporate announcements (pipeline updates, financing, or partnership news) that may have motivated the concentrated buying. The derivative conversions suggest a capital structure event may be in progress.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 2 $12.29entry
- T+1 · 2d ago +3.82%α +2.17% · $12.76
- T+3 · todayOpen
- T+5 · in 4d Pending
- T+20 · in 26d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two ARCH Venture affiliates purchased a combined 1.27 million shares of Aspen Neuroscience at $15 per share on November 2, 2026, totaling $19 million in open-market buys. The purchases are non-10b5-1 and represent a material vote of confidence from the company's largest institutional holders, though no corporate catalyst is disclosed in the filing.
Key Financial Metrics
Key Facts
- ARCH Venture Fund X, L.P. purchased 66,667 shares at $15 for $1.0M on 2026-11-02 (open-market, no 10b5-1 plan)
- ARCH Venture Partners XIV, L.P. purchased 1,200,000 shares at $15 for $18.0M on 2026-11-02 (open-market, no 10b5-1 plan)
- Total open-market purchases: $19.0M from two 10% owner affiliates
- Additional non-cash derivative conversions by ARCH entities and a director occurred on the same date, totaling zero economic value
- Market cap not provided; $19M is material relative to the $326M market cap implied by the recent insider activity context (2 buys totaling $19M)
Financial Impact
$19 million in open-market purchases by two 10% owner affiliates at $15/share
Risk Factors
- No corporate catalyst or reason for the purchases is disclosed in the filing
- Derivative conversions by the same entities on the same day could indicate a broader capital restructuring
- Market cap not provided; proportionality assessment relies on implied $326M cap from recent insider activity context
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ASPE-1793674257329 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Nov 3, 2026 2d ago | SC 13G | $12.29 $12.76 | ▲ +3.82% | ▲ +2.17% | $11.76 (−4.31%) |
Nov 2, 2026 2d ago | Insider Cluster | $12.29 $12.76 | ▲ +3.82% | ▲ +2.17% | $11.76 (−4.31%) |
Nov 2, 2026 2d ago | Insider Cluster | $12.29 $12.76 | ▲ +3.82% | ▲ +2.17% | $11.76 (−4.31%) |
Nov 2, 2026 3d ago | 8-K | $12.29 $12.76 | ▲ +3.82% | ▲ +2.17% | $11.76 (−4.31%) |
Oct 30, 2026 6d ago | 424B4 | $13.04 $12.29 | ▼ −5.75% | ▼ −6.05% | $11.76 (−9.82%) |
Oct 30, 2026 6d ago | EFFECT | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
Oct 29, 2026 6d ago | Press Release | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
Oct 29, 2026 6d ago | 3 | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
Oct 29, 2026 6d ago | 3 | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
Oct 29, 2026 6d ago | 3 | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers